Shengyong Luo

537 citations
20 papers · 389 indexed · h-index 12
Topics
Neuroinflammation and Neurodegeneration Mechanisms (6 papers)Neurological Disease Mechanisms and Treatments (5 papers)Immune cells in cancer (3 papers)

In The Last Decade

Shengyong Luo

18 papers receiving 383 citations

Peers

Shengyong Luo
Comparison fields: 5 of 86
  • Molecular Biology 166
  • Neurology 98
  • Cancer Research 62
  • Cardiology and Cardiovascular Medicine 39
  • Epidemiology 37
Replace Jhansi Magisetty with:
Jhansi Magisetty India
Chin-San Liu Taiwan
Mengchen Yuan China
Fangfang Li China
Aodi He China
Annelise Vermot France
Zi Wang China
Sandra Espada Spain
Zihui Zheng China
Aditi Aggarwal India
Shengyong Luo relative to Jhansi Magisetty India Jhansi Magisetty's profile →
Citations per field
00.5×4.3×
Jhansi Magisetty · 1×
Citations per year

Countries citing papers authored by Shengyong Luo

Since Specialization
Citations

This map shows the geographic impact of Shengyong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyong Luo more than expected).

Fields of papers citing papers by Shengyong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengyong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyong Luo. The network helps show where Shengyong Luo may publish in the future.

Co-authorship network of co-authors of Shengyong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Shengyong Luo. A scholar is included among the top collaborators of Shengyong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengyong Luo. Shengyong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 9
3 8
4 3
5 10
6 31
7 29
8 17
9 15
10 36
11 17
12 17
13 7
14 23
15 11
16 45
17 26
18 26
19 59
20
Protective effect of total flavone of Camellia against cerebral ischemic injury
0

About Shengyong Luo

Shengyong Luo is a scholar working on Neurology, Biological Psychiatry and Cancer Research, having authored 20 papers that have together received 389 indexed citations. Recurring topics across this work include Neuroinflammation and Neurodegeneration Mechanisms (6 papers), Neurological Disease Mechanisms and Treatments (5 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Neurology (98 citations), Biological Psychiatry (12 citations) and Internal Medicine (17 citations). Shengyong Luo has collaborated with scholars based in China, Saint Kitts and Nevis and United States. Frequent co-authors include Zhiwu Chen, Rui Li, Qinglin Li, Zheng Ma, Xiaoyi Li, Xiangrong Dai, Huan Wu, Yide Qin, Shuo Chen and Hui Cheng. Their work appears in journals such as PLoS ONE, The Science of The Total Environment and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026